Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the un-audited financial results of the Company for the half year ended 30.09.2023 and to take note of the Statutory Auditors' limited review reports thereon.